ClinicalTrials.Veeva

Menu

Genetics of Uveitis

NeuroTherapia, Inc. logo

NeuroTherapia, Inc.

Status

Enrolling

Conditions

Uveitis
Infectious Uveitis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

In order to improve the investigators knowledge about uveitis and the underlying mechanism of disease, the investigators propose collecting blood from patients with uveitis, isolating DNA and sequencing the DNA to identify genetic mutations or associations in these patients.

Enrollment

1,500 estimated patients

Sex

All

Ages

6+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Any patient above with the diagnosis of uveitis.
  • Any patient with a diagnosis of infectious uveitis such as toxoplasmosis retinochoroiditis, herpes associated retinitis.

Exclusion criteria

  • Patients who are unable to give consent
  • Patients in whom an adequated blood sample can not be obtained.

Trial design

1,500 participants in 1 patient group

Uveitis
Description:
Uveitis or infectious uveitis patients

Trial contacts and locations

1

Loading...

Central trial contact

Kimberly M Baynes, BSN, RN, COA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems